Rhythm Pharmaceuticals (RYTM) Cash from Operations (QoQ) (2017 - 2026)
Rhythm Pharmaceuticals (RYTM) Cash from Operations (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.03% |
| Dec 31, 2025 | 4.63% |
| Sep 30, 2025 | -14.19% |
| Jun 30, 2025 | 42.22% |
| Mar 31, 2025 | -114.12% |
| Dec 31, 2024 | 25.26% |
| Sep 30, 2024 | 13.28% |
| Jun 30, 2024 | 28.64% |
| Mar 31, 2024 | -38.66% |
| Dec 31, 2023 | -0.45% |
| Sep 30, 2023 | 28.81% |
| Jun 30, 2023 | -12.78% |
| Mar 31, 2023 | -7.16% |
| Dec 31, 2022 | 27.64% |
| Sep 30, 2022 | -21.07% |
| Jun 30, 2022 | 27.64% |
| Mar 31, 2022 | -32.52% |
| Dec 31, 2021 | -0.78% |
| Sep 30, 2021 | -26.13% |
| Jun 30, 2021 | 5.04% |